🔎 Trials Near Me

Hem › Akut bifentypisk leukemi › Illinois › Chicago

Kliniska studier för Akut bifentypisk leukemi i Chicago, IL

7 studier för Akut bifentypisk leukemi söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekryterarFas 2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
365 Days · Alla kön · Uppdaterad 25 sep. 2026 · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RekryterarFas 1/2
  • The University of Chicago Medical Center, Chicago
30 Days · Alla kön · Uppdaterad 16 sep. 2026 · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekryterarFas 3
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
365 Days – 25 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekryterarFas 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RekryterarFas 1/2
  • University of Illinois at Chicago Cancer Center, Chicago
Ålder 12 till 95 · Alla kön · Uppdaterad 15 apr. 2026 · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

RekryterarFas 1
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Ålder 1 till 40 · Alla kön · Uppdaterad 12 mars 2026 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RekryterarFas 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Ålder 1 till 21 · Alla kön · Uppdaterad 6 dec. 2024 · NCT05476770

Akut bifentypisk leukemi-studier i andra städer

Andra studier i Chicago

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.